Legato Capital Management LLC Acquires Shares of 10,142 Cabot Corporation $CBT

Legato Capital Management LLC acquired a new stake in Cabot Corporation (NYSE:CBT) during the fourth quarter, Holdings Channel.com reports. The fund acquired 10,142 shares of the specialty chemicals company’s stock, valued at approximately $672,000.

Other large investors have also recently made changes to their positions in the company. Ashton Thomas Private Wealth LLC lifted its stake in shares of Cabot by 343.9% in the third quarter. Ashton Thomas Private Wealth LLC now owns 65,561 shares of the specialty chemicals company’s stock valued at $4,986,000 after buying an additional 50,792 shares in the last quarter. Dimensional Fund Advisors LP lifted its position in shares of Cabot by 5.0% during the third quarter. Dimensional Fund Advisors LP now owns 1,556,762 shares of the specialty chemicals company’s stock valued at $118,392,000 after purchasing an additional 73,734 shares in the last quarter. Elo Mutual Pension Insurance Co bought a new position in shares of Cabot during the third quarter valued at about $1,040,000. UBS Group AG lifted its position in shares of Cabot by 3.5% during the fourth quarter. UBS Group AG now owns 614,178 shares of the specialty chemicals company’s stock valued at $40,708,000 after purchasing an additional 20,668 shares in the last quarter. Finally, Royce & Associates LP lifted its position in shares of Cabot by 37.5% during the third quarter. Royce & Associates LP now owns 106,980 shares of the specialty chemicals company’s stock valued at $8,136,000 after purchasing an additional 29,202 shares in the last quarter. 93.18% of the stock is owned by institutional investors.

Cabot Stock Up 1.7%

CBT opened at $84.80 on Wednesday. Cabot Corporation has a fifty-two week low of $58.33 and a fifty-two week high of $86.43. The company’s 50-day moving average is $76.48 and its 200 day moving average is $71.70. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.45 and a quick ratio of 0.96. The firm has a market capitalization of $4.38 billion, a P/E ratio of 16.03, a PEG ratio of 10.91 and a beta of 0.78.

Cabot (NYSE:CBT) last posted its quarterly earnings data on Tuesday, May 5th. The specialty chemicals company reported $1.61 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.47 by $0.14. Cabot had a net margin of 7.97% and a return on equity of 21.33%. The business had revenue of $904.00 million during the quarter, compared to the consensus estimate of $900.31 million. During the same quarter last year, the company posted $1.90 earnings per share. The firm’s quarterly revenue was down 3.4% compared to the same quarter last year. Cabot has set its FY 2026 guidance at 6.000-6.50 EPS. Research analysts expect that Cabot Corporation will post 6.32 earnings per share for the current fiscal year.

Cabot Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, June 12th. Investors of record on Friday, May 29th will be issued a dividend of $0.4725 per share. This represents a $1.89 dividend on an annualized basis and a yield of 2.2%. This is a boost from Cabot’s previous quarterly dividend of $0.45. The ex-dividend date is Friday, May 29th. Cabot’s dividend payout ratio is 34.03%.

Analysts Set New Price Targets

A number of research firms recently weighed in on CBT. Mizuho raised their price target on shares of Cabot from $75.00 to $80.00 and gave the company a “neutral” rating in a research report on Wednesday, May 6th. Wall Street Zen raised shares of Cabot from a “hold” rating to a “buy” rating in a research report on Saturday, May 9th. UBS Group raised their price target on shares of Cabot from $81.00 to $86.00 and gave the company a “neutral” rating in a research report on Friday, May 8th. Jefferies Financial Group reissued a “buy” rating and set a $85.00 price target on shares of Cabot in a research report on Wednesday, February 4th. Finally, JPMorgan Chase & Co. raised their price target on shares of Cabot from $68.00 to $70.00 and gave the company an “underweight” rating in a research report on Wednesday, May 13th. One research analyst has rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, Cabot presently has a consensus rating of “Hold” and a consensus price target of $80.25.

Cabot Company Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.